Topics

Glioblastoma | Prognosis

Home > Publications > Topics > Glioblastoma > Prognosis

□ OVERVIEW

□ ARTIFICIAL INTELLIGENCE

■ BIOMARKERS

□ BODY MASS INDEX

□ CAROTID ARTERY CALCIUM SCORE

□ CELLULAR HETEROGENEITY

□ CEREBELLAR

□ CIRCULATING CELLS

□ CONTRAST ENHANCEMENT

□ CUPROPTOSIS

□ EDEMA

□ ELDERLY PATIENTS

□ EPILEPSY

□ EXTENT OF RESECTION

□ EXTRACELLULAR VESICLES

□ FIBRINOGEN

□ FRAILTY

□ GENE EXPRESSION

□ GLIOSARCOMA

□ IMMUNOTHERAPY

□ LOCATION OF THE TUMOR

□ MAGNETIC RESONANCE IMAGING

□ METABOLIC SYNDROME

□ METASTASES

□ MGMT METHYLATION

□ MULTIFOCAL TUMOR

□ NEUROGENIC ZONES

□ NOMOGRAMS

□ PLATELET-TO-LYMPHOCYTE RATIO (PLR) AND NEUTROPHIL-TO-LYMPHOCYTE RATIO (NLR)

□ POSITRON EMISSION TOMOGRAPHY

□ PREOPERATIVE BLOOD ELEMENTS

□ PREOPERATIVE TUMOR GROWTH

□ PRETREATMENT TUMOR SHAPE

■ PROGNOSTIC SCORES

□ RECURRENCE

□ RESPONSE

□ SEX-SPECIFIC DIFFERENCES

□ STUPP PROTOCOL

□ SURGERY

SURVIVAL

□ OVERALL SURVIVAL

□ POSTOPERATIVE SURVIVAL

□ SHORT-TERM SURVIVAL

□ LONG-TERM SURVIVAL

□ EXTREME LONG-TERM SURVIVAL

□ TEMPORAL MUSCLE THICKNESS

□ TESTOSTERONE

□ THERAPY TIMING

□ TUMOR TREATING FIELDS